Eli Lilly的库存在新的体重损失药片显示 3阶段试验结果大有希望后猛增了 Eli Lilly's stock jumps after new weight-loss pill shows promising Phase 3 trial results.

Eli Lilly的库存在公司宣布第3阶段试验取得积极成果后猛增, Eli Lilly's stock surged after the company announced positive results from a Phase 3 trial for its new oral weight-loss pill. 该药物帮助病人平均失去了体重的10.5%,降低了血糖水平,提高了市场对其监管批准和商业潜力的信心。 The drug helped patients lose an average of 10.5% of their body weight and reduced blood sugar levels, boosting market confidence in its regulatory approval and commercial potential. 股票增加了4.22%,在星期二增至724.66美元。 Shares rose by 4.22% to $724.66 on Tuesday.